Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 57,326 | 216,312 | 288,586 | 124,984 | 32,778 |
| Depreciation Amortization | 147,406 | 86,681 | 74,229 | 7,827 | 8,711 |
| Income taxes - deferred | -49,254 | -10,097 | -113,862 | 0 | 0 |
| Accounts receivable | -55,041 | -48,846 | -4,724 | -12,293 | -9,768 |
| Accounts payable and accrued liabilities | -37,966 | 5,089 | -7,286 | 2,080 | 891 |
| Other Working Capital | -60,509 | -80,958 | -5,157 | -3,652 | -5,707 |
| Other Operating Activity | 405,644 | 120,250 | 17,966 | 32,650 | 31,963 |
| Operating Cash Flow | $407,606 | $288,431 | $249,752 | $151,596 | $58,868 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 75,791 | -75,853 | 0 |
| PPE Investments | -36,347 | -9,976 | -5,976 | -1,279 | -731 |
| Net Acquisitions | -828,676 | N/A | -448,609 | N/A | N/A |
| Purchase Sale Intangibles | -202,626 | -6,288 | -16,500 | -4,500 | -4,000 |
| Other Investing Activity | -202,626 | -6,288 | -16,500 | -4,100 | -1,412 |
| Investing Cash Flow | $-1,067,649 | $-16,264 | $-395,294 | $-81,232 | $-2,143 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,194,385 | 553,425 | 450,916 | 0 | 48,427 |
| Debt Repayment | -309,524 | -465,910 | -11,875 | -41,668 | -127,828 |
| Common Stock Issued | 58,487 | 30,703 | 25,003 | 16,419 | 62,408 |
| Common Stock Repurchased | -42,215 | -136,484 | 0 | 0 | N/A |
| Other Financing Activity | -190,099 | -5,590 | -15,514 | -7,833 | -10,533 |
| Financing Cash Flow | $711,034 | $-23,856 | $448,530 | $-33,082 | $-27,526 |
| Exchange Rate Effect | -3,453 | 997 | 2,132 | 0 | 0 |
| Beginning Cash Position | 636,504 | 387,196 | 82,076 | 44,794 | 15,595 |
| End Cash Position | 684,042 | 636,504 | 387,196 | 82,076 | 44,794 |
| Net Cash Flow | $47,538 | $249,308 | $305,120 | $37,282 | $29,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | 407,606 | 288,431 | 249,752 | 151,596 | 58,868 |
| Capital Expenditure | -36,347 | -9,976 | -5,976 | -1,279 | -731 |
| Free Cash Flow | 371,259 | 278,455 | 243,776 | 150,317 | 58,137 |